Glassman Wealth Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-132
| Closed | -$13.1K | – | 1188 |
|
|
2023
Q4 | $13.1K | Sell |
132
-251
| -66% | -$25K | ﹤0.01% | 805 |
|
|
2023
Q3 | $39.6K | Buy |
383
+46
| +14% | +$4.75K | 0.01% | 477 |
|
|
2023
Q2 | $40.9K | Buy |
337
+95
| +39% | +$11.5K | 0.01% | 451 |
|
|
2023
Q1 | $37.2K | Sell |
242
-128
| -35% | -$19.7K | 0.01% | 474 |
|
|
2022
Q4 | $66.5K | Buy |
370
+130
| +54% | +$23.4K | 0.01% | 355 |
|
|
2022
Q3 | $28K | Sell |
240
-100
| -29% | -$11.7K | 0.01% | 529 |
|
|
2022
Q2 | $49K | Buy |
340
+75
| +28% | +$10.8K | 0.01% | 403 |
|
|
2022
Q1 | $46K | Buy |
265
+97
| +58% | +$16.8K | 0.01% | 420 |
|
|
2021
Q4 | $43K | Sell |
168
-192
| -53% | -$49.1K | 0.01% | 404 |
|
|
2021
Q3 | $139K | Buy |
360
+43
| +14% | +$16.6K | 0.03% | 190 |
|
|
2021
Q2 | $74K | Buy |
317
+10
| +3% | +$2.33K | 0.02% | 282 |
|
|
2021
Q1 | $40K | Buy |
307
+43
| +16% | +$5.6K | 0.01% | 369 |
|
|
2020
Q4 | $28K | Buy |
264
+52
| +25% | +$5.52K | 0.01% | 440 |
|
|
2020
Q3 | $15K | Buy |
212
+35
| +20% | +$2.48K | ﹤0.01% | 513 |
|
|
2020
Q2 | $11K | Buy |
177
+61
| +53% | +$3.79K | ﹤0.01% | 478 |
|
|
2020
Q1 | $3K | Buy |
+116
| New | +$3K | ﹤0.01% | 628 |
|
|
2019
Q3 | – | Sell |
-13
| Closed | – | – | 1251 |
|
|
2019
Q2 | $0 | Buy |
+13
| New | – | ﹤0.01% | 1254 |
|